Compare FOR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | STAA |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2007 | N/A |
| Metric | FOR | STAA |
|---|---|---|
| Price | $26.44 | $23.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | ★ $31.25 | $24.56 |
| AVG Volume (30 Days) | 128.1K | ★ 1.2M |
| Earning Date | 01-20-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.29 | N/A |
| Revenue | ★ $1,662,400,000.00 | $230,591,000.00 |
| Revenue This Year | $0.58 | N/A |
| Revenue Next Year | $8.73 | $22.61 |
| P/E Ratio | $8.08 | ★ N/A |
| Revenue Growth | ★ 10.14 | N/A |
| 52 Week Low | $18.00 | $13.50 |
| 52 Week High | $29.44 | $30.81 |
| Indicator | FOR | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 40.24 |
| Support Level | $24.88 | $23.03 |
| Resistance Level | $27.24 | $25.35 |
| Average True Range (ATR) | 0.76 | 1.07 |
| MACD | 0.16 | -0.25 |
| Stochastic Oscillator | 76.45 | 14.67 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.